NCT04654221View on ClinicalTrials.gov

Evaluation of Renal Function in Subjects Who Had Undergone Cardiac Surgery

TerminatedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

February 21, 2020

Primary Completion Date

February 25, 2021

Study Completion Date

March 26, 2021

Conditions
Cardiac Surgery
Interventions
DIAGNOSTIC_TEST

mGFR by iohexol clearance

Iohexol 5mL injection (300 mg iodine/mL) will be administered to all subjects to determine mGFR by iohexol clearance

Trial Locations (6)

27710

Duke University Medical Center, Durham

32055

Multi-Specialty Research Associates, Inc., Lake City

33713

Advance Medical Research, St. Petersburg

36608

CB Flock Research, Mobile

91325

Valley Clinical Trials, Northridge

91723

Valley Clinical Trials, Covina

Sponsors
All Listed Sponsors
lead

Quark Pharmaceuticals

INDUSTRY